Exact Sciences

We love our interns! It’s #NationalInternDay and we are lucky to be celebrating 106 talented individuals from all over the country. Our interns complete projects across several business functions and still find time to volunteer in their communities. It’s safe to say they have already made an impact this summer. #WeAreExact

Despite progress against colorectal cancer, continuing racial disparities mean Black adults are still more likely to develop and die from this disease. A new paper, published in Journal of the National Cancer and based on research sponsored by Exact Sciences, offers new opportunities to address these disparities. The model predicts that eliminating racial disparities in follow-up colonoscopy and colonoscopy quality would dramatically reduce colorectal cancer incidence and deaths among Black adults. Read more here: https://lnkd.in/gsQNeYCw Thank you to all the co-authors for your collaboration on this important work. Together, we’ll continue to work to address health equity in cancer care.

Being re-certified as a Great Place To Work US for the 6th consecutive year means our efforts towards fostering a positive, collaborative, and innovative workplace are making a difference. We are thankful for our incredible team; with their input, we can continuously grow and improve to ensure Exact Sciences is a great place to work for all. #WeAreExact

Join us in congratulating our very own Jorge Garces on being recognized as a San Diego Business Journal Leader of Influence in Life Sciences! Congratulations, Jorge, and thanks for all you do to advance our purpose to help eradicate cancer. https://bit.ly/3WBmF8n

Great article about the importance of personalized cancer care below. Follow our Exact Sciences Precision Oncology page for more updates!

Breast cancer care has come a long way, including a shift towards personalized treatment with tools like the Oncotype DX® test, which provides insights based on an individual’s specific tumor biology. Read more about the importance of expanding global access to these genomic tests via Open Access Government: https://bit.ly/3zP85lQ

Our commitment to supporting cancer patients and survivors starts within our own four walls. Through our new cancer survivors inclusion network, we’re working to uplift teammates who have been touched by cancer and create a workplace community where they have access to the necessary connections and resources. Find out more: https://bit.ly/3Y9eAtH

We are committed to increasing awareness and improving access to colorectal cancer (CRC) screenings through our FOCUS Program. We recently awarded our largest group of grants, and we’re eager to see how these organizations will make an impact. Read more about the FOCUS grant awards here: https://bit.ly/46d1FZY

On Wednesday, the FDA approved an investigational device exemption (IDE) for Exact Sciences’ multi-cancer early detection (MCED) test, clearing the way for the test’s use in clinical studies. It’s a key milestone in our development of a rigorous and comprehensive MCED program. We look forward to the next phase, the launch of real-world evidence studies, in the coming months. The achievement wouldn’t be possible without the dedication, grit, and innovative spirit of the Exact Sciences team. Thank you for all you do.

We were proud to partner with the NAHJ (National Association of Hispanic Journalists) to lead an impactful discussion around disparities in cancer outcomes for Latinos and how journalists can help educate and advocate for the community. Thank you to Veronica Descotte and our expert panelists, Regina Barragan, Marielle McLeod, MHA, CPN, and Marcela Mazo Canola for sharing your expertise. #NAHJ2024.